跳至主要内容
临床试验/IRCT20240411061470N1
IRCT20240411061470N1已完成Unknown

Effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on osteoarthritis-related pain, quality of life and physical function: a randomized, double-blind, placebo-controlled study

Ondokuz Mayis University0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Diagnosed with unilateral or bilateral Kellgren and Lawrence radiographic grade 2 or 3 knee OA for more than 3 months
  • Non-vegetarian
  • Willing to participate in all scheduled visits and tests

排除标准

  • Kellgren and Lawrence diagnosed with radiographic grade 1 or 4 knee OA
  • Any history of trauma, fracture or surgery on the index joint
  • Evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases or malignancies within the last 5 years
  • History of hypersensitivity to the rescue medication or any of the products used in the study
  • Active viral or bacterial infection according to clinical examination
  • Expected knee arthroscopy or arthroplasty or life-threatening pathology
  • Received intra-articular injections or corticosteroids in the target knee joint (the most painful knee at screening) within the last 6 months
  • Patients with intolerance to protein-based foods or supplements, pregnant or breastfeeding women and those with alcohol dependence

研究者

相似试验